XY-049
N/A
Report date: 2025/01/26 17:54:37
NME
Base Information
Drug NameXY-049
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChangchun Haiyue Pharmaceutical Limited By Share Ltd
China Registration ClassN/A
Develop Information
Active CompaniesChangchun Haiyue Pharmaceutical Limited By Share Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A